Keyphrases
Denmark
100%
National Cohort Study
50%
Chronic Hepatitis C
46%
People Living with HIV (PLHIV)
38%
Pre-exposure Prophylaxis (PrEP)
35%
Hepatitis C
31%
Sustained Virological Response
27%
AIDS/HIV
23%
Pegylated Interferon
21%
Ribavirin
17%
Incidence Rate
17%
Hepatitis C Virus
17%
Confidence Interval
16%
Hepatitis B
16%
Genotype
15%
Viral Load
15%
Matched Cohort Study
14%
Hepatitis
13%
Men Who Have Sex with Men
13%
Sexual Exposure
12%
Childbirth
11%
HIV Diagnosis
11%
Direct-acting Antivirals
11%
Length of Stay
11%
Spontaneous Preterm Birth (sPTB)
11%
Safety-engineered Devices
11%
Liver Stiffness
11%
Hepatocellular Carcinoma
11%
GNB5
11%
Population-based Study
11%
Severe Acute Respiratory Syndrome Coronavirus 2 Infection
11%
Linkage to Care
11%
Cirrhosis
11%
Antiviral Treatment
11%
Melioidosis
11%
HIV-exposed Uninfected children
11%
Infected Patients
11%
Travellers
11%
Diagnostic Challenge
11%
Risk Compensation
11%
Induced Abortion
11%
Low Incidence
11%
Blood Exposure
11%
Migrants
11%
During Pregnancy
11%
Ribavirin Treatment
11%
Apoptotic Genes
11%
Randomized Controlled Trial
11%
Short Course
11%
Interferon-α (IFN-α)
11%
Medicine and Dentistry
Human Immunodeficiency Virus
62%
Cohort Analysis
60%
Chronic Hepatitis C
49%
Infection
37%
Hepatitis C Virus
19%
Population
17%
Peginterferon
16%
Ribavirin
16%
Antivirus Agent
14%
Antiviral Therapy
14%
Men Who Have Sex with Men
12%
Randomized Controlled Trial
11%
Tularemia
11%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Breast Cancer
11%
Pre-Exposure Prophylaxis
11%
Malignant Neoplasm
11%
Hepatocellular Carcinoma
11%
Antibiotic Therapy
11%
Gram Negative Sepsis
11%
Liver Cirrhosis
11%
Gene Linkage
11%
Melioidosis
11%
Proteinase Inhibitor
11%
Diagnosis
11%
Resistance Mutation
11%
Neurological Complication
11%
Epstein-Barr Virus Infection
11%
Virus Resistance
11%
Middle Age
11%
Lymphadenopathy
9%
Treatment Response
8%
Infectious Mononucleosis
7%
Antibiotics
7%
All Cause Mortality
6%
Arm
5%
Tick Bite
5%
Proteinase
5%
Mortality Rate
5%
Hepatitis C
5%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
57%
Chronic Hepatitis C
52%
Cohort Study
48%
Infection
39%
Antivirus Agent
26%
Ribavirin
26%
Peginterferon
26%
Hepatitis C Virus
25%
Adverse Event
12%
Proteinase Inhibitor
11%
Virus Resistance
11%
Spontaneous Abortion
11%
Hepatitis C Virus Genotype 3
11%
Liver Cell Carcinoma
11%
Vertical Transmission
11%
Liver Cirrhosis
11%
SARS Coronavirus
11%
Needlestick Injury
11%
Interferon
11%
Chlamydiae
11%
B Cell Lymphoma
11%
Gonorrhea
11%
Hepatitis B Virus
11%
Clinical Trial
8%
Hepatitis C
8%
Hepatitis B
8%
Infection Rate
7%
Syphilis
7%
Proteinase
5%
Hepatitis C Virus Genotype 1
5%
